StockNews.com Initiates Coverage on BIOLASE (NASDAQ:BIOL)
Research analysts at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the medical technology company’s stock. BIOLASE Stock Performance Shares of BIOL opened at $0.01 on Wednesday. BIOLASE has a fifty-two week low of $0.02 and […]
Research analysts at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the medical technology company’s stock. BIOLASE Stock Performance Shares of BIOL opened at $0.01 on Wednesday. BIOLASE has a fifty-two week low of $0.02 and […]
